His primary areas of investigation include Cancer research, Genetics, microRNA, Breast cancer and Gene. The various areas that Joel S. Parker examines in his Cancer research study include DNA methylation, Immunology, KRAS, Carcinoma and ARID1A. Joel S. Parker focuses mostly in the field of Genetics, narrowing it down to matters related to Computational biology and, in some cases, DNA microarray, Gene silencing and Genome.
His work in microRNA addresses issues such as PBRM1, which are connected to fields such as GNAS complex locus, Pancreatic cancer, Proteomic Profiling, Chromatin and Signal transduction. His work in the fields of Claudin-Low overlaps with other areas such as Invasive Lobular Breast Carcinoma. The Internal medicine study combines topics in areas such as Oncology and Pathology.
His primary areas of investigation include Cancer research, Internal medicine, Oncology, Breast cancer and Cancer. As a part of the same scientific study, Joel S. Parker usually deals with the Cancer research, concentrating on Carcinoma and frequently concerns with Head and neck squamous-cell carcinoma. Joel S. Parker studied Internal medicine and Pathology that intersect with Phenotype.
The study incorporates disciplines such as Exome sequencing, Colorectal cancer, Clinical trial and Proportional hazards model in addition to Oncology. His Breast cancer research integrates issues from Metastasis and Gene expression profiling. As a part of the same scientific family, Joel S. Parker mostly works in the field of Cancer, focusing on Gene and, on occasion, Computational biology.
His primary scientific interests are in Internal medicine, Oncology, Cancer research, Breast cancer and Cancer. His research in Oncology intersects with topics in Exome sequencing, Clinical trial, FOLFIRI, Proportional hazards model and Colorectal cancer. His Cancer research research is multidisciplinary, relying on both Carcinogenesis, Immune system, Immunotherapy and Mutation.
His Breast cancer research is multidisciplinary, incorporating perspectives in Transcriptome, Metastasis and Gene. His Gene research entails a greater understanding of Genetics. His research links Pik3ca mutation with Cancer.
Joel S. Parker focuses on Cancer research, Breast cancer, Internal medicine, Computational biology and Oncology. He combines subjects such as Tumor microenvironment, Mammary tumor and Immunotherapy with his study of Cancer research. Breast cancer is the subject of his research, which falls under Cancer.
His Internal medicine research incorporates themes from Classifier and Epigenetics. Joel S. Parker interconnects RNA, Genome, DNA, Cytotoxic T cell and Major histocompatibility complex in the investigation of issues within Computational biology. His work deals with themes such as Nurses' Health Study, Prospective cohort study, Clinical trial, Methylation and Disease, which intersect with Oncology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt;Robert S. Fulton;Michael D. McLellan;Heather Schmidt.
Repeated observation of breast tumor subtypes in independent gene expression data sets
Therese Sørlie;Robert Tibshirani;Joel Parker;Trevor Hastie.
Proceedings of the National Academy of Sciences of the United States of America (2003)
The cancer genome atlas pan-cancer analysis project
John N Weinstein;John N Weinstein;Eric A. Collisson;Gordon B Mills;Kenna R Mills Shaw;Kenna R Mills Shaw.
Nature Genetics (2013)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker;Michael Mullins;Maggie C.U. Cheang;Samuel Leung.
Journal of Clinical Oncology (2009)
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Michael S. Lawrence;Carrie Sougnez;Lee Lichtenstein;Kristian Cibulskis.
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton;Margaret Morgan;Preethi H. Gunaratne;Preethi H. Gunaratne;David A. Wheeler.
Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network
Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger.
Integrated genomic characterization of endometrial carcinoma
Gad Getz;Stacey B. Gabriel;Kristian Cibulskis;Eric Lander.
Comprehensive molecular characterization of urothelial bladder carcinoma
John N Weinstein;Rehan Akbani;Bradley McIntosh Broom;Wenyi Wang.
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang;Stephen K Chia;David Voduc;Dongxia Gao.
Journal of the National Cancer Institute (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: